Skip to content
Cancer — Platinum chemotherapyATC L01XA03

Oxaliplatin

Prescription onlyWHO essential medicine

Platinum chemotherapy used mainly for bowel cancer, causing cold-triggered nerve symptoms.

Starts working
Depends on the cancer and regimen
Half-life
Long terminal half-life (about 4–5 days platinum)
In use since
—
Pregnancy
Usually avoided

Overview

Oxaliplatin is part of FOLFOX and CAPOX regimens for colorectal cancer. A typical side effect is tingling and pain in the hands, feet and throat triggered by cold.

How it works

Damages cancer cell DNA so the cells die.

Oxaliplatin belongs to the Platinum chemotherapy. How Platinum chemotherapy work: bind DNA strands together so cancer cells cannot divide.

Uses

  • Colorectal cancer
  • Stomach and pancreatic cancer (in regimens)

Available as: iv infusion.

Typical dose

Adults
Dosed by your cancer team according to the treatment protocol.
Good to know
Doses depend on body size, blood counts and the regimen.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Cold-triggered tingling
  • Nausea
  • Diarrhoea
  • Tiredness
  • Low blood counts

Serious — get medical help

Uncommon, but need prompt attention

  • Lasting nerve damage
  • Severe allergic reactions
  • Low blood counts

Warnings

  • Avoid cold drinks, ice and cold air during and after infusion
  • Report numbness that lasts between cycles

Who should avoid it

  • Severe nerve damage
  • Severe low blood counts
  • Allergy to platinum drugs
  • Pregnancy

Interactions

  • Nephrotoxic drugs — added kidney effects
  • Live vaccines — avoid

Other medicines in the atlas that need care with Oxaliplatin, grouped by the reason:

Added bone marrow suppressionModerateWith Azathioprine, Bortezomib, Capecitabine, Carbimazole, Carboplatin and 26 more
Combined kidney toxicityModerateWith Aceclofenac, Amikacin, Amphotericin B, Aspirin, Bleomycin and 22 more
Bleeding risk with low plateletsModerateWith Aspirin, Cilostazol, Clopidogrel, Dipyridamole, Prasugrel and 1 more

Antiplatelet treatment adds to bleeding risk when another medicine suppresses platelet production.

What's usually done: Monitor blood counts and report unusual bruising or bleeding.

Check Oxaliplatin against your own medicines

Using it safely

Alcohol
Best to limit. Alcohol can add to nausea and tiredness; ask your cancer team.
Food and drink
Follow your cancer team's advice.
If you miss a dose
Contact your cancer team; do not double up.
Stopping it
Only your cancer team should change or stop treatment.
Driving
Tiredness or dizziness may affect driving.
Tests and checks
Nerve symptoms; Blood counts; Kidney function
If too much is taken
Overdose can cause severe low blood counts or organ damage. Seek emergency help.
Storage
Refrigerate unless the label says otherwise.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Usually avoided

Can harm a developing baby. Effective contraception is advised during and after treatment.

Breastfeeding

Usually avoided

Avoid breastfeeding during treatment.

Special groups

Kidney disease
Dose may need adjusting; your team will advise.
Liver disease
Dose may need adjusting; your team will advise.
Older adults
Older adults may be more sensitive to side effects.

Brand names

United States
Eloxatin
United Kingdom
Eloxatin
India
Oxaliplatin (generic), Oxitan
Australia
Eloxatin

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Oxaliplatin?

Yes — Oxaliplatin is prescription-only in most countries.

Can I take Oxaliplatin during pregnancy?

Usually avoided. Can harm a developing baby. Effective contraception is advised during and after treatment. Always check with a doctor or midwife.

How quickly does Oxaliplatin work?

Depends on the cancer and regimen.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.